McKesson acquires Prism Vision Holdings
McKesson acquired an approximate 80% controlling interest in Prism Vision Holdings, an ophthalmology and retina management services provider, for about $850 million.
McKesson has completed its previously announced acquisition of a controlling interest in Prism Vision Holdings, a leading provider of general ophthalmology and retina management services.
McKesson acquired an approximate 80% controlling interest in Prism Vision Holdings, an ophthalmology and retina management services provider, for about $850 million. Prism physicians will retain an approximate 20% interest.
[Read more: McKesson augments integrated pharmacy services for specialty clinics]
McKesson said the acquisition enables the company to develop a retinal and ophthalmology platform and expand McKesson’s differentiated value proposition, clinical services and distribution offerings.